ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "longitudinal studies and systemic sclerosis"

  • Abstract Number: 1734 • 2018 ACR/ARHP Annual Meeting

    Association of Short-Term Longitudinal Changes in Clinical and Physiologic Variables with Overall Survival in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD)

    Vincent Sobanski1, Jeska de Vries-Bouwstra2, Anna-Maria Hoffmann-Vold3, Dörte Huscher4, Margarida Alves5, Marco Matucci-Cerinic6, Gabriela Riemekasten7, Mengtao Li8, Gabriele Valentini9, László Czirják10, Otylia Kowal-Bielecka11, Yannick Allanore12, Nils Schoof5 and Oliver Distler13, 1Department of Internal Medicine and Clinical Immunology, University of Lille, Lille, France, 2Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 3Oslo University Hospital, Oslo, Norway, 4Charité – Universitaetsmedizin Berlin and Berlin Institute of Health, Berlin, Germany, 5Boehringer Ingelheim International GmbH, Ingelheim, Germany, 6Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy, 7Rheumatology, University Hospital Schleswig-Holstein - Campus Lübeck, Lübeck, Germany, 8Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, 9Department of Rheumatology, Second University of Naples, Napoli, Italy, 10Department of Rheumatology and Immunology, University of Pécs, Pécs, Hungary, 11Department of Rheumatology and Internal Medicine, Medical University of Białystok, Białystok, Poland, 12Cochin Hospital, Paris Descartes University, Paris, France, Paris, France, 13Department of Rheumatology, University Hospital Zurich, Zurich, Switzerland

    Background/Purpose: Interstitial lung disease (ILD) is one of the leading causes of morbidity and mortality in patients with SSc. However, the impact of changes in…
  • Abstract Number: 1089 • 2014 ACR/ARHP Annual Meeting

    Trajectories of Disability over Time Among Patients with Systemic Sclerosis

    Sarah D. Mills1, Rina S. Fox1, Shadi Gholizadeh2, Scott C. Roesch1,3, Murray Baron4,5, Marie Hudson6,7, Russell Steele6,8, Brett D. Thombs6,9 and Vanessa L. Malcarne1,10, 1SDSU/UCSD Joint Doctoral Program in Clinical Psychology, San Diego, CA, 2Psychology, SDSU/UCSD Joint Doctoral Program in Clinical Psychology, San Diego, CA, 3Psychology, San Diego State University, San Diego, CA, 4Pavillion A, Rm 216, Jewish General Hospital, Montreal, QC, Canada, 5McGill University, Montreal, QC, Canada, 6Jewish General Hospital, Montreal, QC, Canada, 7Division of Rheumatology, McGill University, Montreal, QC, Canada, 8Mathematics, McGill University, Montreal, QC, Canada, 9Psychiatry, McGill University, Montreal, QC, Canada, 10San Diego State University, San Diego, CA

    Background/Purpose Systemic Sclerosis (SSc) is often associated with disability, which worsens over time. However, there is considerable heterogeneity in the rate of patients’ disability progression.…
  • Abstract Number: 697 • 2013 ACR/ARHP Annual Meeting

    Longitudinal Assessment Of Pulmonary Function In 304 Norwegian Patients With Systemic Sclerosis

    Anna-Maria Hoffmann-Vold1, Torhild Garen2, Oyvind Midtvedt1, May-Brit Lund3, Jan Tore Gran1 and Øyvind Molberg4, 1Rheumatology, Oslo University Hospital, Oslo, Norway, 2Department of Rheumatology, Oslo University Hospital Rikshospitalet, Oslo, Norway, 3Pulmonary Unit, Oslo University Hospital, Rikshopitalet, Oslo, Norway, 4Oslo University Hospital, Oslo, Norway

    Background/Purpose: The purpose of this study was to asses sequential pulmonary function measurements (forced vital capacity [FVC] % predicted) in a large systemic sclerosis (SSc)…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology